Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.70 |
| ▸ | TSHR | P16473 | 7/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9464153 | 0.98 | THRB (0.68) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL14706828 | 0.98 | THRB (0.68) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL9568827 | 0.96 | THRB (0.70) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL2742411 | 0.96 | THRB (0.70) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL3103061 | 0.94 | TSHR (0.71) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL9066861 | 0.93 | TSHR (0.70) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL9066134 | 0.93 | TSHR (0.70) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL9066855 | 0.93 | TSHR (0.70) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL9066211 | 0.93 | TSHR (0.70) | THRBTSHRHTTPOLBAPEX1 | |
| SCHEMBL8850814 | 0.93 | TSHR (0.70) | THRBTSHRHTTPOLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11970443-B2 | Crosslinking agent compound and superabsorbent polymer prepared by using the same | LG CHEM, LTD. (KR) | 2024-04-30 | — | — | US | disclosed |
| EP-3725762-B1 | NOVEL CROSSLINKER COMPOUND AND SUPERABSORBENT POLYMER PREPARED USING SAME | LG CHEMICAL LTD (KR) | 2024-02-28 | — | — | EP | disclosed |
| EP-3540001-B1 | HIGHLY ABSORPTIVE RESIN AND METHOD FOR PRODUCING SAME | LG CHEMICAL LTD (KR) | 2023-01-04 | — | — | EP | disclosed |
| US-20200369595-A1 | Novel Crosslinking Agent Compound and Superabsorbent Polymer Prepared by Using the Same | LG CHEM, LTD. (KR) | 2020-11-26 | — | — | US | disclosed |
| EP-3725762-A1 | NOVEL CROSSLINKER COMPOUND AND SUPERABSORBENT POLYMER PREPARED USING SAME | LG CHEM, LTD. (KR) | 2020-10-21 | — | — | EP | disclosed |
| US-20190344243-A1 | Superabsorbent Polymer and Preparation Method Thereof | LG CHEM, LTD. (KR) | 2019-11-14 | — | — | US | disclosed |
| EP-3540001-A1 | HIGHLY ABSORPTIVE RESIN AND METHOD FOR PRODUCING SAME | LG Chem, Ltd. (KR) | 2019-09-18 | — | — | EP | disclosed |
| US-20140194524-A1 | Methods for Treating Alzheimer's Disease | COGNITION PHARMACEUTICALS, LLC (US) | 2014-07-10 | — | — | US | disclosed |
| EP-1635851-B1 | METHODS FOR TREATING COGNITIVE IMPAIRMENT AND IMPROVING COGNITION | COGNITION PHARMACEUTICALS LLC (US) | 2013-10-16 | — | — | EP | disclosed |
| US-20130231395-A1 | METHODS FOR TREATING ALZHEIMER'S DISEASE | COGNITION PHARMACEUTICALS, LLC (US) | 2013-09-05 | — | — | US | disclosed |
| US-20030229122-A1 | Use of methylphenidate compounds to enhance memory | SENTION, INC. | 2003-12-11 | — | — | US | disclosed |
| US-20030119884-A1 | Methods and compositions for regulating memory consolidation | PANMEDIX, INC. | 2003-06-26 | — | — | US | disclosed |
| EP-1315495-A2 | USE OF THREO-METHYLPHENIDATE COMPOUNDS TO ENHANCE MEMORY | Sention, Inc. (US) | 2003-06-04 | — | — | EP | disclosed |
| US-20020132793-A1 | Use of methylphenidate compounds to enhance memory | SENTION INC. | 2002-09-19 | — | — | US | disclosed |
| US-20020115725-A1 | Methods and compositions for regulating memory consolidation | PRIESTLEY, KATHERINE (GB) | 2002-08-22 | — | — | US | disclosed |
| US-20020103162-A1 | Use of threo-methylphenidate compounds to enhance memory | SENTION, INC. | 2002-08-01 | — | — | US | disclosed |
| WO-2002039998-A2 | METHODS AND COMPOSITIONS FOR REGULATING MEMORY CONSOLIDATION | SENTION, INC. (US) | 2002-05-23 | — | — | WO | disclosed |
| WO-2002017920-A2 | USE OF METHYLPHENIDATE COMPOUNDS TO ENHANCE MEMORY | SENTION, INC (US) | 2002-03-07 | — | — | WO | disclosed |
| WO-2002017919-A2 | USE OF THREO-METHYLPHENIDATE COMPOUNDS TO ENHANCE MEMORY | SENTION, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| EP-0922709-A1 | PROCESS FOR PRODUCING (METH)ACRYLATE DERIVATIVES | NOF CORPORATION (JP) | 1999-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194524-A1 | Methods for Treating Alzheimer's Disease | CHAT, ACHE, PNMT | THRB 2687/4885TSHR 4699/4885HTT 36/4885 |
| US-20020132793-A1 | Use of methylphenidate compounds to enhance memory | PNMT, CHAT, SLC6A3 | THRB 3199/4885TSHR 4167/4885HTT 843/4885 |
| US-20020103162-A1 | Use of threo-methylphenidate compounds to enhance memory | SLC6A3, SLC6A2, PNMT | THRB 706/4885TSHR 2465/4885HTT 684/4885 |
| US-11970443-B2 | Crosslinking agent compound and superabsorbent polymer prepared by using the same | NOTUM, PCNA, UROD | THRB 4882/4885TSHR 4474/4885HTT 3975/4885 |
| US-20030229122-A1 | Use of methylphenidate compounds to enhance memory | PNMT, GRIN3B, GRIN3A | THRB 2079/4885TSHR 3560/4885HTT 605/4885 |
| US-20130231395-A1 | METHODS FOR TREATING ALZHEIMER'S DISEASE | CHAT, ACHE, PNMT | THRB 2687/4885TSHR 4699/4885HTT 36/4885 |
| US-20030119884-A1 | Methods and compositions for regulating memory consolidation | BDNF, CHAT, DCX | THRB 4401/4885TSHR 4650/4885HTT 1554/4885 |
| US-20020115725-A1 | Methods and compositions for regulating memory consolidation | BDNF, CHAT, GAP43 | THRB 3535/4885TSHR 4489/4885HTT 1533/4885 |
| US-20200369595-A1 | Novel Crosslinking Agent Compound and Superabsorbent Polymer Prepared by Using the Same | NOTUM, UROD, STOM | THRB 4883/4885TSHR 4495/4885HTT 4172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.